Capital Flow Monitor · Sponsors · CIK 2108969
Starget Pharma Inc.
2031 KINGS HIGHWAY, SHREVEPORT, LA, 71103 · 318-746-8430
Biotechnology · Corporation· inc. DELAWARE true 2025
Fit score
—
Offering
$22.2M
Sold
$16.4M
% sold
73.9%
Investors
29
Min investment
$50K
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-02-03 | D ·current | 506(b) | $22.2M | $16.4M | 73.9% | 29 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Sigal Kalmanson Cusnir — Executive Officer, Tzofit, L3
- Ronen Kalmanson — Director, Ramat Hasharon, L3
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.